Article Details

Pfizer Gets EC OK for Lorviqua as First-Line Treatment for ALK-Positive Advanced Lung ...

Retrieved on: 2022-01-28 18:08:35

Tags for this article:

Click the tags to see associated articles and topics

Pfizer Gets EC OK for Lorviqua as First-Line Treatment for ALK-Positive Advanced Lung .... View article details on hiswai:

Excerpt

By Colin Kellaher Pfizer Inc. on Friday said the European Commission has approved the expanded use of Lorviqua as monotherapy for adults with ...

Article found on: www.marketwatch.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up